Heartland Advisors Inc. Grows Position in Integer Holdings Corporation $ITGR

Heartland Advisors Inc. lifted its position in shares of Integer Holdings Corporation (NYSE:ITGR) by 2.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 247,977 shares of the medical equipment provider’s stock after purchasing an additional 5,262 shares during the quarter. Integer comprises 1.1% of Heartland Advisors Inc.’s investment portfolio, making the stock its 12th biggest holding. Heartland Advisors Inc. owned approximately 0.73% of Integer worth $21,822,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. WINTON GROUP Ltd purchased a new stake in shares of Integer in the 4th quarter worth about $4,836,000. Jennison Associates LLC purchased a new position in Integer during the 4th quarter valued at about $1,036,000. Kestrel Investment Management Corp purchased a new position in Integer during the 4th quarter valued at about $5,933,000. William Blair Investment Management LLC lifted its position in Integer by 70.1% during the 4th quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock valued at $36,735,000 after acquiring an additional 192,956 shares during the period. Finally, F m Investments LLC boosted its stake in Integer by 26.3% during the fourth quarter. F m Investments LLC now owns 64,070 shares of the medical equipment provider’s stock worth $5,025,000 after acquiring an additional 13,340 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Down 4.1%

NYSE:ITGR opened at $95.56 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The firm has a market cap of $3.25 billion, a P/E ratio of 23.83, a P/E/G ratio of 2.27 and a beta of 0.64. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $116.31. The firm has a 50-day simple moving average of $91.53 and a two-hundred day simple moving average of $87.50.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). The firm had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Analysts predict that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ITGR shares. Truist Financial lifted their target price on shares of Integer from $97.00 to $110.00 and gave the company a “buy” rating in a report on Thursday. Piper Sandler reissued an “overweight” rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Citigroup raised their price objective on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Finally, Zacks Research downgraded Integer from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $101.14.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.